ELOXX PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 6.19 thousand shares for the 12-month period ending 2017-06-30, per its 10-K filed 2017-10-13.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2017-10-13
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-06-30 was 354.00 shares, a 6.84% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-03-31 was 465.00 shares, a 41.77% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-12-31 was 3.48K shares, a 91.83% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-09-30 was 1.90K shares, a 250.55% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 6.19K shares, a 85.85% decline from fiscal 2016.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2016 was 43.77K shares, a 1119.36% increase from fiscal 2015.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2015 was 3.59K shares, a 14.48% increase from fiscal 2014.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2014 was 3.14K shares, a 9.08% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2017-06-30 | 354.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 819.00 shares derived: sum of 2 quarters · filed 2017-10-13 | 4.29K shares derived: sum of 3 quarters · filed 2017-10-13 | 6.19K shares 10-K · filed 2017-10-13 | |
| 2017-03-31 | 465.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | 3.94K shares derived: sum of 2 quarters · filed 2017-05-22 | 5.84K shares 10-Q · filed 2017-05-22 | 6.22K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-12-31 | 3.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | 5.38K shares 10-Q · filed 2017-02-10 | 5.75K shares derived: sum of 3 quarters · filed 2017-10-13 | 6.08K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-09-30 | 1.90K shares 10-Q · filed 2016-11-14 | 2.28K shares derived: sum of 2 quarters · filed 2017-10-13 | 2.61K shares derived: sum of 3 quarters · filed 2017-10-13 | 45.13K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-06-30 | 380.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 708.00 shares derived: sum of 2 quarters · filed 2017-10-13 | 43.23K shares derived: sum of 3 quarters · filed 2017-10-13 | 43.77K shares 10-K · filed 2017-10-13 | |
| 2016-03-31 | 328.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | 42.85K shares derived: sum of 2 quarters · filed 2016-05-12 | 43.40K shares 10-Q · filed 2016-05-12 | 43.59K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-12-31 | 42.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | 43.07K shares 10-Q · filed 2016-02-16 | 43.26K shares derived: sum of 3 quarters · filed 2017-10-13 | 43.26K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-09-30 | 542.00 shares 10-Q · filed 2015-11-16 | 735.00 shares derived: sum of 2 quarters · filed 2017-10-13 | 735.00 shares derived: sum of 3 quarters · filed 2017-10-13 | 4.13K shares derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-06-30 | 193.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | 193.00 shares derived: sum of 2 quarters · filed 2017-10-13 | 3.59K shares derived: sum of 3 quarters · filed 2017-10-13 | 3.59K shares 10-K · filed 2017-10-13 | |
| 2015-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | 3.40K shares derived: sum of 2 quarters · filed 2015-05-14 | 3.40K shares 10-Q · filed 2015-05-14 | 3.58K shares derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-12-31 | 3.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | 3.40K shares 10-Q · filed 2015-02-17 | 3.58K shares derived: sum of 3 quarters · filed 2016-10-13 | 3.81K shares derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-14 | 181.00 shares derived: sum of 2 quarters · filed 2016-10-13 | 415.00 shares derived: sum of 3 quarters · filed 2016-10-13 | 3.14K shares derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-06-30 | 181.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | 415.00 shares derived: sum of 2 quarters · filed 2016-10-13 | 3.14K shares derived: sum of 3 quarters · filed 2016-10-13 | 3.14K shares 10-K · filed 2016-10-13 | |
| 2014-03-31 | 234.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | 2.96K shares derived: sum of 2 quarters · filed 2014-05-09 | 2.96K shares 10-Q · filed 2014-05-09 | -191.67K shares derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-12-31 | 2.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | 2.72K shares 10-Q · filed 2014-02-14 | -191.90K shares derived: sum of 3 quarters · filed 2015-10-09 | -16.90K shares derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-14 | -194.63K shares derived: sum of 2 quarters · filed 2015-10-09 | -19.63K shares derived: sum of 3 quarters · filed 2015-10-09 | ||
| 2013-06-30 | -194.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | -19.63K shares derived: sum of 2 quarters · filed 2015-10-09 | 2.88K shares 10-K · filed 2015-10-09 | 287.50K shares 10-K · filed 2013-09-11 | |
| 2013-03-31 | 175.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | 197.50K shares 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | 22.50K shares 10-Q · filed 2013-02-14 | ||||
| 2012-06-30 | 9.75K shares 10-K · filed 2014-09-29 | 975.00K shares 10-K/A · filed 2012-10-26 | |||
| 2011-06-30 | 500.00K shares 10-K · filed 2013-09-11 | ||||
| 2010-06-30 | 233.00K shares 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |